Paragon 28, Inc.

Equities

FNA

US69913P1057

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:02 2024-04-29 pm EDT			5-day change	1st Jan Change
9.12 ^USD	+3.64%		-9.25%	-26.63%

Apr. 04	Sector Update: Health Care Stocks Slump Late Afternoon	MT
Apr. 04	Sector Update: Health Care	MT

Paragon 28, Inc. Reaffirms Net Revenue Guidance for Fiscal Year 2024

April 04, 2024 at 08:01 am EDT

Paragon 28, Inc. reaffirmed revenue guidance for fiscal year 2024. For the year, the company reaffirms its prior 2024 net revenue guidance and continues to expect net revenue to be $249 million to $259 million, representing 15.1% and 19.7% reported growth compared to 2023.

Latest news about Paragon 28, Inc.

Sector Update: Health Care Stocks Slump Late Afternoon	Apr. 04	MT
Sector Update: Health Care	Apr. 04	MT
Paragon 28 Shares Slump After Announcing Preliminary Q1 Revenue, CFO Resignation	Apr. 04	MT
Paragon 28, Inc. Reaffirms Net Revenue Guidance for Fiscal Year 2024	Apr. 04	CI
Paragon 28, Inc. Announces Chief Financial Officer Changes	Apr. 04	CI
Paragon 28, Inc. Announces Board Changes	Apr. 04	CI
Paragon 28, Inc. Provides Revenue Guidance for the First Quarter 2024	Apr. 03	CI
Paragon 28, Inc. Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler®? R3INFORCE?? Extraosseous Repair System	Mar. 28	CI
Paragon 28 Insider Bought Shares Worth $255,226, According to a Recent SEC Filing	Mar. 19	MT
Needham Ups Price Target on Paragon 28 to $17 From $16, Keeps Buy Rating	Mar. 01	MT
Paragon 28 Narrows Q4 Loss, Revenue Increases; Sets 2024 Outlook	Feb. 29	MT
Transcript : Paragon 28, Inc., Q4 2023 Earnings Call, Feb 29, 2024	Feb. 29
Earnings Flash (FNA) PARAGON 28 Reports Q4 Revenue $60.6M, vs. Street Est of $60.5M	Feb. 29	MT
Paragon 28, Inc. Provides Earnings Guidance for the Fiscal Year 2024	Feb. 29	CI
Paragon 28, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Paragon 28, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
Paragon 28, Inc. Launches Precision®? Mis Bunion System Offering Surgeons A Guided Minimally Invasive Surgical Solution for Treating Patients with Bunions	Feb. 01	CI
Paragon 28, Inc. Announces the Launch of the FJ2000? Power Console and Burr System Designed Specifically for Foot and Ankle Procedures	Jan. 30	CI
Paragon 28, Inc. Launches the Mister Tendon? Harvester System ? the First and Only Minimally Invasive Harvesting System for Fhl and Fdl Tendon Transfer Procedures	Jan. 26	CI
Paragon 28 Announces First Cases and Limited Market Release of the Bun-Yo-Matic? ? A Next Generation Clamp and Cut Guide System for Lapidus Bunion Procedures	Jan. 17	CI
Transcript : Paragon 28, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 03:00 PM	Jan. 08
Paragon 28, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2023	Jan. 08	CI
Paragon 28, Inc. Announce the Launch of the Grappler Knotless Anchor System and Bridgeline Tape	Jan. 05	CI
Paragon 28, Inc. Launches Beast Cortical Fibers	Nov. 14	CI
Paragon 28 Launches Jaws Great White Staple System Further Expanding Its Nitinol Staple Offering	Nov. 14	CI

Chart Paragon 28, Inc.

Duration

Period

More charts

Company Profile

Paragon 28, Inc. is a medical device company. The Company develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products and product families include plates and plating systems, screws, staples, and nails to address all foot and ankle procedures, including fracture fixation, forefoot, or hallux valgus, which includes bunion and hammertoe, ankle, flatfoot, or progressive collapsing foot deformity (PCDF), Charcot foot and Ortho biologics. It provides a comprehensive portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. The Companyâs suite of surgical solutions comprises 75 product systems, including approximately 9,200 SKUs, which comprises of approximately 6,800 implants, 1,400 instruments and 1,000 disposable and other SKUs. Its products are available in a variety of sizes and configurations to suit the individual patientâs anatomical and surgical requirements.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-08 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Paragon 28, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

8.8 USD

Average target price

18 USD

Spread / Average Target

+104.55%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
PARAGON 28, INC.	-26.63%	730M
ABBOTT LABORATORIES	-2.54%	187B
MEDTRONIC PLC	-1.85%	106B
BECTON, DICKINSON AND COMPANY	-4.26%	66.9B
DEXCOM, INC.	+1.39%	49.45B
CENCORA, INC.	+16.82%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+3.49%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+0.65%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution